加味四君子汤治疗缓解期溃疡性结肠炎:系列N-of-1双盲随机对照试验的研究方案
本研究为单中心、医院来源的双盲N-of-1试验系列,计划纳入10例缓解期溃疡性结肠炎患者,进行3个周期、每周期两个8周治疗期的随机交叉比较,干预分别为加味四君子汤联合美沙拉秦安慰剂与美沙拉秦联合加味四君子汤安慰剂,无洗脱期,采用配对t检验和混合效应模型分析症状视觉模拟评分与生活质量问卷。
要点
- 加味四君子汤治疗缓解期溃疡性结肠炎的疗效需更严谨临床试验评估。
- 采用N-of-1双盲随机对照设计,比较加味四君子汤与美沙拉秦的疗效。
- 主要分析指标为临床症状VAS与生活质量问卷,用配对t检验和混合效应模型。
核心结论
- 研究旨在比较加味四君子汤与美沙拉秦治疗缓解期溃疡性结肠炎的疗效。
- 预期结果将显示加味四君子汤对缓解期溃疡性结肠炎患者有效。
研究设计与样本
- 单中心、医院来源、双盲N-of-1试验,计划纳入10例单一受试者。
- 计划进行3个N-of-1试验周期,每周期包含两个8周治疗期,无洗脱期。
关键数值与推荐
- 每个8周治疗期内随机接受加味四君子汤联合美沙拉秦安慰剂或美沙拉秦联合加味四君子汤安慰剂。
- 采用配对t检验和混合效应模型分析临床症状视觉模拟评分(VAS)与生活质量问卷。
- 受试者由研究者严格按照纳入与排除标准选择。
局限性
- 研究结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Modified Sijunzi decoction (SJZD) has been used to treat ulcerative colitis (UC) in remission. However, more rigorous clinical trials are necessary to evaluate its effectiveness. Therefore, a series of single-case randomised controlled trials (N-of-1 trials) is proposed to compare the efficacy of modified SJZD with mesalazine for treating UC in remission. METHODS: This is a single-site, hospital-based, double-blind N-of-1 trial for 10 single subjects. Three cycles of N-of-1 trials are planned. There are two treatment periods in each cycle. Modified SJZD combined with mesalazine placebo or mesalazine combined with modified SJZD placebo will be randomised during each 8-week treatment period. There is no washout period in the study. Subjects will be selected by the researcher strictly in accordance with the inclusion and exclusion criteria. DISCUSSION: Paired t tests and mixed-effect models will be used to analyse the visual analogue scale (VAS) for clinical symptoms and the quality of life questionnaire responses. The findings will be interpreted with caution. We anticipate that the results will show that modified SJZD is effective for patients with UC in remission. TRIAL REGISTRATION: Chinese Clinical Trial Register, ID: ChiCTR1900024086. Registered on 24 June 2019.
引用
- Chen YM, Deng JM, Wen Y, et al. Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials. Trials. 2020. PMID: 32398112. doi:10.1186/s13063-020-04315-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。